Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice

We investigated first-line (1L) treatment patterns and predictors of taxane use to better understand the evolving metastatic triple-negative breast cancer (mTNBC) treatment landscape. This retrospective analysis of the Truven Health MarketScan(®) (Somers, NY, USA) Database included women with mTNBC...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Shaughnessy, Joyce, Emens, Leisha A., Chui, Stephen Y., Wang, Wei, Russell, Kenneth, Lin, Shih-Wen, Avile, Carlos Flores, Luhn, Patricia, Schneeweiss, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293053/
https://www.ncbi.nlm.nih.gov/pubmed/34287291
http://dx.doi.org/10.3390/curroncol28040239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293053/
https://www.ncbi.nlm.nih.gov/pubmed/34287291
http://dx.doi.org/10.3390/curroncol28040239

Ejemplares similares